Evaluation of EGFR gene copy number as a predictive biomarker for the efficacy of cetuximab in combination with chemotherapy in the first-line treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck: EXTREME study

Background: The phase III EXTREME study demonstrated that combining cetuximab with platinum/5-fluorouracil (5-FU) significantly improved overall survival in the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) compared with pl...

Descripción completa

Detalles Bibliográficos
Autores principales: Licitra, L., Mesia, R., Rivera, F., Remenár, É., Hitt, R., Erfán, J., Rottey, S., Kawecki, A., Zabolotnyy, D., Benasso, M., Störkel, S., Senger, S., Stroh, C., Vermorken, J. B.
Formato: Texto
Lenguaje:English
Publicado: Oxford University Press 2011
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3082162/
https://www.ncbi.nlm.nih.gov/pubmed/21048039
http://dx.doi.org/10.1093/annonc/mdq588

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3082162/
https://www.ncbi.nlm.nih.gov/pubmed/21048039
http://dx.doi.org/10.1093/annonc/mdq588

Ejemplares similares